Advertisement

Topics

Companies Related to "Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu" [Most Relevant Company Matches] RSS

07:02 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu" found in our extensive corporate database of over 50,000 company records.

Showing "Desloratadine Phenylephrine Ibuprofen Compared Placebo Treatment Symptoms Associated" Companies 1–25 of 3,400+

Relevant

Cypress Bioscience

We are committed to being the innovator and leader in providing products for the treatment of patients with Functional Somatic Syndromes, such as Fibromyalgia Syndrome, or FMS, and other central nervous system disorders. Specifically, our strategy involves acquiring or in-licensing central nervous system, or CNS, active compounds and developing them for novel and typically underserved indications....


Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...


vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

National MS Society

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to loss of vision and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us ...

National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances ...

Horizon Pharma, Inc.

Horizon Pharma, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and chronic inflammation. Horizon's product portfolio includes innovative therapies in early- and late-stage development that are designed to improve the efficacy, safety and quality of life for patients with chronic pain and inflammati...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

Metris Therapeutics

Established in 1996, Metris now has several products in development. These are a treatment for endometriosis, a treatment for menorrhagia / dysmenorrhea, using a proprietary vaginal drug delivery system, and an oral treatment for chronic symptoms associated with the menopause. Metris intends to license its products to third parties for late stage clinical development and commercialisation. Metris ...

PLx Pharma

PLx Pharma is a privately-owned pharmaceutical company developing proprietary formulations of proven nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, naproxen and ibuprofen which possess significantly improved gastrointestinal (GI) safety profiles. Based on PLx’s unique phospholipid based drug delivery technology, these products are desi...

Asthma, Allergy & Immunology Clinic

Allergic rhinitis or "hay fever." Symptoms of allergic rhinitis are sneezing, congestion, itching and dripping of the nose, and itchy, watery eyes. There are basically two types of allergic rhinitis: seasonal (for example, during fall, spring, or both) and perennial (year-round). Seasonal allergic rhinitis refers to allergies caused by pollen from trees, grasses, and/or weeds. Perennial allergic r...

The Rory Staunton Foundation

The Rory Staunton Foundation seeks to ensure that no other young person or adult dies of sepsis because of lack of recognition of the deadly symptoms by the medical community and responsible authorities and to serve a major information source for the medical condition's symptoms and outreach efforts.

Atlanta Allergy and Asthma Clinic

Atlanta Allergy and Asthma Clinic is the premier facility in the Southeast for the treatment of allergy, asthma, and immunologic diseases. We know that living with the symptoms of allergy and asthma can range from being annoying to potentially life threatening. That is why our entire focus is on you our patient. From research, to prevention, to the latest in treatment options, our goal is helping ...

Janssen Pharmaceuticals

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, N.J. and is the only large pharmaceutical company in the U.S. dedicated solely to mental health. It currently markets prescription medications for the treatment of schizophrenia, bipolar mania and the treatment of symptoms associated with autistic disorder. Ortho-McNeil-Janssen Pharmaceuticals, Inc. is a membe...

DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a comm...

Prescription Dispensing Laboratories

Prescription Dispensing Laboratories announces a major discovery related to the use of calcium channel blockers for the noninvasive, topically applied transdermal treatment of Peyronie's Disease, Dupuytren's Contracture, Plantar Fibromatosis and related connective tissue disorders worldwide patents are pending). Accept no imitations. Transdermal verapamil is available only from PDLABS.A comparison...

Paragon BioTeck, Inc.

Paragon BioTeck, Inc. is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon’s portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. These products include the Comfortear® Lacrisolve™...

Viamet Pharmaceuticals Inc.

Viamet is a biopharmaceutical company focused on the discovery, development and commercialization of novel antifungal agents based on its proprietary metalloenzyme medicinal chemistry platform, the Metallophile® Technology. Metalloenzymes are enzymes that contain a metal, such as iron, zinc or copper, which is linked to the enzyme’s protein compone...

Buoy

Buoy is a free digital health tool that helps people – from the moment they get sick – start their health care on the right foot. Started by a team of doctors and computer scientists working at the Harvard Innovation Laboratory in Boston MA, Buoy was developed in direct response to the downward spiral we’ve all faced when we attempt to self-...

Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute ...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Ipsen Biopharmaceuticals, Inc.

*MAS responders week 4: 74% to Dysport® 500 units, 79% to Dysport® 1000 units and 23% to placebo

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

Parkinson?s Unity Walk

Parkinson's disease is the second most common chronic neurological disorder in older adults after Alzheimer's, affecting approximately one percent of people over age 60. Approximately 15 percent of patients develop Parkinson's disease before the age of 50. Every nine minutes someone is diagnosed with Parkinson's disease. Symptoms include tremor, muscle rigidity, slowed motion, shuffling gait, and ...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...


More From BioPortfolio on "Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks